Eiger BioPharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Eiger BioPharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q4 2023.
Eiger BioPharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $683K, a 62.9% decline year-over-year.
Eiger BioPharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $5.01M, a 39.8% decline year-over-year.
Eiger BioPharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.01M, a 39.8% decline from 2022.
Eiger BioPharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.32M, a 5.27% increase from 2021.
Eiger BioPharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.9M, a 32.3% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q4 2023	$5.01M	$683K	-$1.16M	-62.9%	Oct 1, 2023	Dec 31, 2023	10-K	2024-04-08
Q3 2023	$6.17M	$1.04M	-$1.18M	-53.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$7.35M	$745K	-$1.46M	-66.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$8.81M	$2.54M	+$495K	+24.2%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$8.32M	$1.84M	-$124K	-6.31%	Oct 1, 2022	Dec 31, 2022	10-K	2024-04-08
Q3 2022	$8.44M	$2.22M	-$108K	-4.64%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$8.55M	$2.21M	+$150K	+7.29%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$8.4M	$2.05M	+$498K	+32.2%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$7.9M	$1.96M	+$527K	+36.7%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-17
Q3 2021	$7.37M	$2.33M	+$885K	+61.2%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$6.49M	$2.06M	+$596K	+40.8%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$5.89M	$1.55M	-$80K	-4.91%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$5.97M	$1.44M	+$89K	+6.6%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-17
Q3 2020	$5.88M	$1.45M	-$204K	-12.4%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$6.09M	$1.46M	-$25K	-1.68%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$6.11M	$1.63M	+$434K	+36.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$5.68M	$1.35M	-$163K	-10.8%	Oct 1, 2019	Dec 31, 2019	10-K	2022-03-10
Q3 2019	$5.84M	$1.65M	+$477K	+40.7%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	$5.37M	$1.49M	+$166K	+12.6%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	$5.2M	$1.2M	+$192K	+19.1%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	$5.01M	$1.51M	+$491K	+48.1%	Oct 1, 2018	Dec 31, 2018	10-K	2021-03-09
Q3 2018	$4.52M	$1.17M	+$219K	+23%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	$4.3M	$1.32M	+$375K	+39.6%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018	$3.92M	$1M	-$321K	-24.2%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q4 2017	$4.24M	$1.02M	-$418K	-29.1%	Oct 1, 2017	Dec 31, 2017	10-K	2020-03-13
Q3 2017	$4.66M	$953K	-$287K	-23.1%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-09
Q2 2017	$4.95M	$946K	+$772K	+444%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-10
Q1 2017	$4.18M	$1.32M	+$986K	+292%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-11
Q4 2016	$3.19M	$1.44M	+$1.28M	+828%	Oct 1, 2016	Dec 31, 2016	10-K	2019-03-14
Q3 2016	$1.91M	$1.24M	+$1.22M	+5536%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-09
Q2 2016	$689K	$174K	+$127K	+270%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-11
Q1 2016	$562K	$338K	+$335K	+11167%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-12
Q4 2015	$227K	$155K	+$2.31M		Oct 1, 2015	Dec 31, 2015	10-K	2018-03-09
Q3 2015	-$2.08M	$22K	-$889K	-97.6%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-08
Q2 2015	-$1.19M	$47K	-$701K	-93.7%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-10
Q1 2015	-$489K	$3K	-$516K	-99.4%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-16
Q4 2014	$27K	-$2.15M	-$1.13M	-111%	Oct 1, 2014	Dec 31, 2014	10-K	2017-03-23
Q3 2014	$1.16M	$911K	+$99K	+12.2%	Jul 1, 2014	Sep 30, 2014	10-Q	2014-11-12
Q2 2014	$1.06M	$748K	+$561K	+300%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-11
Q1 2014	$501K	$519K	+$440K	+557%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-15
Q4 2013	$60.7K	-$1.02M			Oct 1, 2013	Dec 31, 2013	8-K/A	2016-06-17
Q3 2013		$812K			Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-12
Q2 2013		$187K			Apr 1, 2013	Jun 30, 2013	10-Q	2014-08-07
Q1 2013		$79K			Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.